PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Chart, page-3476

  1. 201 Posts.
    lightbulb Created with Sketch. 44
    Very robust arguments above. Conclusion is this then. This taking off before 2025/2026 is much less likely than facing another credit raising at these ‘ridiculously’ - yet totally understandably - low SP, as before. Make sure you are a plastic surgeon or something like that with tonnes of disposable income to throw at this once another CR occurs, or face having your holding diluted by up who knows how much - 11% thus far, so 20%, 30%? Don’t know. And the next time you read a tweet or see football players jumping over hoops and doing backflips after a shot of PPS, know it will do nothing ti the SP: only a major positive FDA move will do that. I heard someone say that PR is against a deal….as of big Pharma is lining up outside his door. If they were, surely we would know by now. Which makes me think they are not. I also wish I can read the contract with Bene Pharma.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.